InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001415889-23-002504 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-02-14 2023-02-10+ HALO Torley Helen Pres AND CEO, Dir M - OptEx $0.00 +64.1K 634.8K +11% $0
DM 2023-02-14 2023-02-10+ HALO Torley Helen Pres AND CEO, Dir F - Tax $48.92 -33.7K 602.0K -5% -$1.65M
DM 2023-02-14 2023-02-10+ HALO Torley Helen Pres AND CEO, Dir M - OptEx $0.00 -64.1K 31.3K -67% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-10 M A 31,281 $0.00 618,458 D — —
2 Common Common Stock 2023-02-12 F D 17,266 $48.92 617,517 D — — (F2) The reported disposition of 17,266 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
3 Common Common Stock 2023-02-12 M A 32,794 $0.00 634,783 D — —
4 Common Common Stock 2023-02-10 F D 16,469 $48.92 601,989 D — — (F1) The reported disposition of 16,469 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
5 Derivative Restricted Stock Units 2023-02-12 M D 32,794 $0.00 0 D $0.00 · — to — 32,794 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
6 Derivative Restricted Stock Units 2023-02-10 M D 31,281 $0.00 31,281 D $0.00 · — to — 31,281 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.